Cargando…
Analysis of Adverse Effects of COVID-19 Vaccines in Spain following Booster Dose
The present study evaluates the adverse effects of three vaccines: AstraZeneca (Vaxzevria), Pfizer/BioNTech (Comirnaty) and Moderna (Spikevax) according to the dose. From 733 participants collected, the vaccine schedule was as follows: 330 (45%) received a double dose of the AstraZeneca vaccine, 382...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504129/ https://www.ncbi.nlm.nih.gov/pubmed/36146475 http://dx.doi.org/10.3390/vaccines10091397 |
_version_ | 1784796138298146816 |
---|---|
author | Ríos, Esther Medrano, Sara Martínez, Mercedes Novella, Consuelo Marcos, Esther Fernández, Jose J. Delgado-Iribarren, Alberto Culebras, Esther |
author_facet | Ríos, Esther Medrano, Sara Martínez, Mercedes Novella, Consuelo Marcos, Esther Fernández, Jose J. Delgado-Iribarren, Alberto Culebras, Esther |
author_sort | Ríos, Esther |
collection | PubMed |
description | The present study evaluates the adverse effects of three vaccines: AstraZeneca (Vaxzevria), Pfizer/BioNTech (Comirnaty) and Moderna (Spikevax) according to the dose. From 733 participants collected, the vaccine schedule was as follows: 330 (45%) received a double dose of the AstraZeneca vaccine, 382 (52.1%) received a double dose of Pfizer, 18 (2.5%) received a heterologous prime boost and 3 (0.4%) received a single dose. Pfizer and Moderna vaccines were administered as a third dose in 70 and 121 individuals, respectively. Local and systemic reactions observed in the three vaccines were mild to moderate in severity. Only one AstraZeneca recipient (0.3%) presented a serious adverse effect: blurred vision. Adverse events were more frequent after the first dose of AstraZeneca and after the second dose of Pfizer. As the third dose, Moderna causes more adverse effects than Pfizer regardless of the type of vaccine previously administered, whereas the reactogenicity of a third dose of Pfizer is slightly higher in the group previously vaccinated with Pfizer than in that group with AstraZeneca. In short, secondary effects of the third dose of COVID-19 vaccines were similar to those after dose 2, but their frequency depends on the type of vaccine and the combinations of vaccines. |
format | Online Article Text |
id | pubmed-9504129 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95041292022-09-24 Analysis of Adverse Effects of COVID-19 Vaccines in Spain following Booster Dose Ríos, Esther Medrano, Sara Martínez, Mercedes Novella, Consuelo Marcos, Esther Fernández, Jose J. Delgado-Iribarren, Alberto Culebras, Esther Vaccines (Basel) Article The present study evaluates the adverse effects of three vaccines: AstraZeneca (Vaxzevria), Pfizer/BioNTech (Comirnaty) and Moderna (Spikevax) according to the dose. From 733 participants collected, the vaccine schedule was as follows: 330 (45%) received a double dose of the AstraZeneca vaccine, 382 (52.1%) received a double dose of Pfizer, 18 (2.5%) received a heterologous prime boost and 3 (0.4%) received a single dose. Pfizer and Moderna vaccines were administered as a third dose in 70 and 121 individuals, respectively. Local and systemic reactions observed in the three vaccines were mild to moderate in severity. Only one AstraZeneca recipient (0.3%) presented a serious adverse effect: blurred vision. Adverse events were more frequent after the first dose of AstraZeneca and after the second dose of Pfizer. As the third dose, Moderna causes more adverse effects than Pfizer regardless of the type of vaccine previously administered, whereas the reactogenicity of a third dose of Pfizer is slightly higher in the group previously vaccinated with Pfizer than in that group with AstraZeneca. In short, secondary effects of the third dose of COVID-19 vaccines were similar to those after dose 2, but their frequency depends on the type of vaccine and the combinations of vaccines. MDPI 2022-08-25 /pmc/articles/PMC9504129/ /pubmed/36146475 http://dx.doi.org/10.3390/vaccines10091397 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ríos, Esther Medrano, Sara Martínez, Mercedes Novella, Consuelo Marcos, Esther Fernández, Jose J. Delgado-Iribarren, Alberto Culebras, Esther Analysis of Adverse Effects of COVID-19 Vaccines in Spain following Booster Dose |
title | Analysis of Adverse Effects of COVID-19 Vaccines in Spain following Booster Dose |
title_full | Analysis of Adverse Effects of COVID-19 Vaccines in Spain following Booster Dose |
title_fullStr | Analysis of Adverse Effects of COVID-19 Vaccines in Spain following Booster Dose |
title_full_unstemmed | Analysis of Adverse Effects of COVID-19 Vaccines in Spain following Booster Dose |
title_short | Analysis of Adverse Effects of COVID-19 Vaccines in Spain following Booster Dose |
title_sort | analysis of adverse effects of covid-19 vaccines in spain following booster dose |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504129/ https://www.ncbi.nlm.nih.gov/pubmed/36146475 http://dx.doi.org/10.3390/vaccines10091397 |
work_keys_str_mv | AT riosesther analysisofadverseeffectsofcovid19vaccinesinspainfollowingboosterdose AT medranosara analysisofadverseeffectsofcovid19vaccinesinspainfollowingboosterdose AT martinezmercedes analysisofadverseeffectsofcovid19vaccinesinspainfollowingboosterdose AT novellaconsuelo analysisofadverseeffectsofcovid19vaccinesinspainfollowingboosterdose AT marcosesther analysisofadverseeffectsofcovid19vaccinesinspainfollowingboosterdose AT fernandezjosej analysisofadverseeffectsofcovid19vaccinesinspainfollowingboosterdose AT delgadoiribarrenalberto analysisofadverseeffectsofcovid19vaccinesinspainfollowingboosterdose AT culebrasesther analysisofadverseeffectsofcovid19vaccinesinspainfollowingboosterdose |